Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Averill Julianne | Director | 2 | $0 | $0 | 2026-06-10 |
| Ray Sumita | Director | 7 | $0 | $0 | 2026-06-10 |
| Faust Elizabeth | Director | 5 | $0 | $0 | 2026-06-10 |
| AGUIAR ERIC | Director | 6 | $0 | $0 | 2026-06-10 |
| Hitchcock Michael J.M. | Interim CEO | 10 | $239.3K | $0 | 2026-04-01 |
| Erdtmann Rainer M | See Remarks | 29 | $3.86M | $0 | 2026-04-01 |
| Chen Bihua | Director, 10% Owner | 2 | $0 | $0 | 2025-06-11 |
| Valle Franco | Chief Financial Officer | 13 | $173.5K | $0 | 2024-11-30 |
| Cormorant Global Healthcare Master Fund, LP | 10% Owner | 2 | $12.00M | $0 | 2024-06-12 |
| Frias Juan Pablo | Chief Medical Officer | 3 | $0 | $0 | 2024-05-31 |
| Butler Thomas Andrew | Chief Executive Officer | 7 | $3.62M | $0 | 2024-01-17 |
| A2A Pharmaceuticals, Inc. | 10% Owner | 12 | $805.4K | $32.80M | 2023-06-01 |
| Cormorant Asset Management, LP | 10% Owner | 4 | $15.30M | $0 | 2022-06-22 |
| Biomea Health, LLC | 10% Owner | 1 | $0 | $0 | 2022-06-01 |
| Stergiopoulos Sotirios | Director | 2 | $379.9K | $0 | 2021-09-17 |
| Cormorant Private Healthcare Fund III LP | 10% Owner | 1 | $0 | $0 | 2021-04-15 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Averill Julianne | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 173,711 | — | $0 | 173,711 | SEC↗ |
| Ray Sumita | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 196,299 | — | $0 | 196,299 | SEC↗ |
| AGUIAR ERIC | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 196,299 | — | $0 | 196,299 | SEC↗ |
| Faust Elizabeth | Director | A Award deriv | 2026-06-10 | 2026-06-12 | 196,299 | — | $0 | 196,299 | SEC↗ |
| Hitchcock Michael J.M. | Interim CEO | A Award deriv | 2026-04-01 | 2026-04-03 | 667,477 | — | $0 | 667,477 | SEC↗ |
| Erdtmann Rainer M | See Remarks | A Award deriv | 2026-04-01 | 2026-04-03 | 452,512 | — | $0 | 452,512 | SEC↗ |
| Erdtmann Rainer M | See Remarks | P Buy | 2025-12-11 | 2025-12-15 | 30,000 | $1.43 | $42.9K | 723,027 | SEC↗ |
| Hitchcock Michael J.M. | Interim CEO | P Buy | 2025-12-02 | 2025-12-04 | 100,000 | $0.99 | $99.0K | 115,000 | SEC↗ |
| Erdtmann Rainer M | See Remarks | P Buy | 2025-12-01 | 2025-12-02 | 10,000 | $1.05 | $10.5K | 693,027 | SEC↗ |
| Erdtmann Rainer M | See Remarks | P Buy | 2025-11-28 | 2025-12-02 | 40,000 | $1.10 | $44.0K | 683,027 | SEC↗ |
| Erdtmann Rainer M | See Remarks | A Award deriv | 2025-08-11 | 2025-08-13 | 1,246,989 | — | $0 | 1,246,989 | SEC↗ |
| Hitchcock Michael J.M. | Interim CEO | A Award deriv | 2025-08-11 | 2025-08-13 | 916,434 | — | $0 | 916,434 | SEC↗ |
| Averill Julianne | Director | A Award deriv | 2025-07-22 | 2025-07-24 | 241,177 | — | $0 | 241,177 | SEC↗ |
| Chen Bihua | Director, 10% Owner | A Award deriv | 2025-06-11 | 2025-06-13 | 91,970 | — | $0 | 91,970 | SEC↗ |
| Ray Sumita | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 91,970 | — | $0 | 91,970 | SEC↗ |
| AGUIAR ERIC | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 91,970 | — | $0 | 91,970 | SEC↗ |
| Faust Elizabeth | Director | A Award deriv | 2025-06-11 | 2025-06-13 | 91,970 | — | $0 | 91,970 | SEC↗ |
| Hitchcock Michael J.M. | Interim CEO | A Award deriv | 2025-03-26 | 2025-03-28 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Erdtmann Rainer M | See Remarks | G Gift | 2025-01-31 | 2025-08-13 | 10,000 | — | $0 | 643,027 | SEC↗ |
| Erdtmann Rainer M | See Remarks | G Gift | 2025-01-31 | 2025-08-13 | 10,000 | — | $0 | 653,027 | SEC↗ |
| Erdtmann Rainer M | See Remarks | G Gift | 2025-01-31 | 2025-08-13 | 10,000 | — | $0 | 19,400 | SEC↗ |
| Erdtmann Rainer M | See Remarks | G Gift | 2025-01-31 | 2025-08-13 | 10,000 | — | $0 | 663,027 | SEC↗ |
| Erdtmann Rainer M | See Remarks | G Gift | 2025-01-31 | 2025-08-13 | 10,000 | — | $0 | 20,000 | SEC↗ |
| Erdtmann Rainer M | See Remarks | G Gift | 2025-01-31 | 2025-08-13 | 10,000 | — | $0 | 20,000 | SEC↗ |
| Erdtmann Rainer M | See Remarks | G Gift | 2025-01-28 | 2025-08-13 | 40,000 | — | $0 | 673,027 | SEC↗ |
| Valle Franco | Chief Financial Officer | A Award | 2024-11-30 | 2024-12-02 | 495 | $6.15 | $3.0K | 42,995 | SEC↗ |
| Hitchcock Michael J.M. | Director | P Buy | 2024-09-30 | 2024-10-01 | 10,000 | $10.06 | $100.6K | 15,000 | SEC↗ |
| AGUIAR ERIC | Director | A Award deriv | 2024-06-12 | 2024-06-13 | 51,025 | — | $0 | 51,025 | SEC↗ |
| Hitchcock Michael J.M. | Director | A Award deriv | 2024-06-12 | 2024-06-13 | 51,025 | — | $0 | 51,025 | SEC↗ |
| Faust Elizabeth | Director | A Award deriv | 2024-06-12 | 2024-06-13 | 51,025 | — | $0 | 51,025 | SEC↗ |
| Ray Sumita | Director | A Award deriv | 2024-06-12 | 2024-06-13 | 51,025 | — | $0 | 51,025 | SEC↗ |
| Cormorant Global Healthcare Ma | 10% Owner | A Award deriv | 2024-06-12 | 2024-06-13 | 51,025 | — | $0 | 51 | SEC↗ |
| Valle Franco | Chief Financial Officer | P Buy | 2024-06-11 | 2024-06-12 | 12,509 | $4.43 | $55.4K | 42,500 | SEC↗ |
| Frias Juan Pablo | Chief Medical Officer | A Award | 2024-05-31 | 2024-06-12 | 349 | $8.94 | $3.1K | 349 | SEC↗ |
| Valle Franco | Chief Financial Officer | A Award | 2024-05-31 | 2024-06-12 | 4,448 | $3.78 | $16.8K | 29,991 | SEC↗ |
| Frias Juan Pablo | Chief Medical Officer | A Award deriv | 2024-01-17 | 2024-01-18 | 111,090 | — | $0 | 111,090 | SEC↗ |
| Erdtmann Rainer M | President and COO | A Award deriv | 2024-01-17 | 2024-01-18 | 135,700 | — | $0 | 135,700 | SEC↗ |
| Valle Franco | Chief Financial Officer | A Award deriv | 2024-01-17 | 2024-01-18 | 145,245 | — | $0 | 145,245 | SEC↗ |
| Butler Thomas Andrew | Chief Executive Officer | A Award deriv | 2024-01-17 | 2024-01-18 | 407,502 | — | $0 | 407,502 | SEC↗ |
| Erdtmann Rainer M | President and COO | G Gift | 2023-12-29 | 2024-01-03 | 3,000 | — | $0 | 10,000 | SEC↗ |
| Erdtmann Rainer M | President and COO | G Gift | 2023-12-29 | 2024-01-03 | 3,000 | — | $0 | 728,027 | SEC↗ |
| Erdtmann Rainer M | President and COO | G Gift | 2023-12-29 | 2024-01-03 | 3,000 | — | $0 | 9,400 | SEC↗ |
| Erdtmann Rainer M | President and COO | G Gift | 2023-12-29 | 2024-01-03 | 3,000 | — | $0 | 10,000 | SEC↗ |
| Erdtmann Rainer M | President and COO | G Gift | 2023-12-29 | 2024-01-03 | 12,000 | — | $0 | 713,027 | SEC↗ |
| Erdtmann Rainer M | President and COO | G Gift | 2023-12-29 | 2024-01-03 | 3,000 | — | $0 | 731,027 | SEC↗ |
| Erdtmann Rainer M | President and COO | G Gift | 2023-12-29 | 2024-01-03 | 3,000 | — | $0 | 725,027 | SEC↗ |
| Valle Franco | Chief Financial Officer | A Award | 2023-11-30 | 2023-12-01 | 1,345 | $3.78 | $5.1K | 25,543 | SEC↗ |
| Frias Juan Pablo | Chief Medical Officer | A Award deriv | 2023-08-31 | 2023-09-01 | 300,000 | — | $0 | 300,000 | SEC↗ |
| AGUIAR ERIC | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 6,989 | — | $0 | 6,989 | SEC↗ |
| Ray Sumita | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 6,989 | — | $0 | 6,989 | SEC↗ |
| Faust Elizabeth | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 6,989 | — | $0 | 6,989 | SEC↗ |
| Chen Bihua | Director, 10% Owner | A Award deriv | 2023-06-14 | 2023-06-16 | 6,989 | — | $0 | 6,989 | SEC↗ |
| Hitchcock Michael J.M. | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 6,989 | — | $0 | 6,989 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | S Sale | 2023-06-01 | 2023-06-02 | 50,000 | $34.56 | $1.73M | 3,500,000 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | S Sale | 2023-05-31 | 2023-06-02 | 75,000 | $33.81 | $2.54M | 3,550,000 | SEC↗ |
| Valle Franco | Chief Financial Officer | A Award | 2023-05-31 | 2023-06-02 | 4,273 | $3.78 | $16.2K | 24,198 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | S Sale | 2023-05-12 | 2023-05-17 | 25,000 | $33.84 | $846.0K | 3,625,000 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | S Sale | 2023-05-09 | 2023-05-10 | 150,000 | $34.50 | $5.17M | 3,650,000 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | S Sale | 2023-05-08 | 2023-05-10 | 100,000 | $33.99 | $3.40M | 3,800,000 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | S Sale | 2023-04-20 | 2023-04-26 | 200,000 | $29.12 | $5.82M | 3,900,000 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | S Sale | 2023-03-31 | 2023-04-06 | 200,000 | $31.25 | $6.25M | 4,100,000 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | S Sale | 2023-03-31 | 2023-04-06 | 200,000 | $31.25 | $6.25M | 4,100,000 | SEC↗ |
| Cormorant Global Healthcare Ma | 10% Owner | P Buy | 2023-03-30 | 2023-04-03 | 400,000 | $30.00 | $12.00M | 3,570,872 | SEC↗ |
| Butler Thomas Andrew | Chief Executive Officer | A Award deriv | 2023-01-06 | 2023-01-10 | 354,350 | — | $0 | 354,350 | SEC↗ |
| Valle Franco | Chief Financial Officer | A Award deriv | 2023-01-06 | 2023-01-10 | 126,300 | — | $0 | 126,300 | SEC↗ |
| Erdtmann Rainer M | President and COO | A Award deriv | 2023-01-06 | 2023-01-10 | 118,000 | — | $0 | 118,000 | SEC↗ |
| Valle Franco | Chief Financial Officer | A Award | 2022-11-30 | 2022-12-02 | 2,518 | $3.78 | $9.5K | 19,925 | SEC↗ |
| Hitchcock Michael J.M. | Director | P Buy | 2022-11-14 | 2022-11-16 | 5,000 | $7.93 | $39.6K | 5,000 | SEC↗ |
| Valle Franco | Chief Financial Officer | P Buy | 2022-11-11 | 2022-11-14 | 4,100 | $7.63 | $31.3K | 17,407 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | P Buy | 2022-08-16 | 2022-08-19 | 30,684 | $13.87 | $425.6K | 4,300,000 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | S Sale | 2022-07-21 | 2022-07-25 | 34,658 | $11.21 | $388.5K | 4,330,684 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | S Sale | 2022-06-24 | 2022-06-28 | 34,658 | $11.76 | $407.6K | 4,365,342 | SEC↗ |
| Cormorant Asset Management, LP | 10% Owner | A Award deriv | 2022-06-22 | 2022-06-24 | 23,867 | — | $0 | 23,867 | SEC↗ |
| Faust Elizabeth | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 45,755 | — | $0 | 45,755 | SEC↗ |
| AGUIAR ERIC | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 23,867 | — | $0 | 23,867 | SEC↗ |
| Hitchcock Michael J.M. | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 23,867 | — | $0 | 23,867 | SEC↗ |
| Ray Sumita | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 23,867 | — | $0 | 23,867 | SEC↗ |
| Biomea Health, LLC | 10% Owner | J Other | 2022-06-01 | 2022-06-03 | 4,365,342 | — | $0 | 0 | SEC↗ |
| Valle Franco | Chief Financial Officer | A Award | 2022-05-31 | 2022-06-01 | 3,307 | $4.67 | $15.4K | 13,307 | SEC↗ |
| Ray Sumita | Director | A Award deriv | 2022-03-03 | 2022-03-07 | 21,461 | — | $0 | 21,461 | SEC↗ |
| Valle Franco | Chief Financial Officer | P Buy | 2022-01-14 | 2022-01-18 | 10,000 | $8.68 | $86.8K | 10,000 | SEC↗ |
| Valle Franco | Chief Financial Officer | A Award deriv | 2021-12-04 | 2021-12-07 | 144,770 | — | $0 | 144,770 | SEC↗ |
| Erdtmann Rainer M | President & COO | A Award deriv | 2021-12-04 | 2021-12-07 | 165,490 | — | $0 | 165,490 | SEC↗ |
| Butler Thomas Andrew | CEO | A Award deriv | 2021-12-04 | 2021-12-07 | 305,400 | — | $0 | 305,400 | SEC↗ |
| Stergiopoulos Sotirios | Director | P Buy | 2021-09-17 | 2021-09-21 | 34,658 | $10.96 | $379.9K | 4,400,000 | SEC↗ |
| A2A Pharmaceuticals, Inc. | 10% Owner | P Buy | 2021-09-17 | 2021-09-21 | 34,658 | $10.96 | $379.9K | 4,400,000 | SEC↗ |
| Butler Thomas Andrew | CEO | P Buy | 2021-08-23 | 2021-08-25 | 24,000 | $13.20 | $316.8K | 228,470 | SEC↗ |
| Erdtmann Rainer M | President & COO | P Buy | 2021-08-23 | 2021-08-25 | 24,000 | $13.20 | $316.8K | 228,470 | SEC↗ |
| Butler Thomas Andrew | CEO | P Buy | 2021-08-18 | 2021-08-19 | 14,000 | $10.77 | $150.8K | 204,470 | SEC↗ |
| Erdtmann Rainer M | President & COO | P Buy | 2021-08-18 | 2021-08-19 | 14,000 | $10.77 | $150.8K | 204,470 | SEC↗ |
| Butler Thomas Andrew | CEO | P Buy | 2021-08-17 | 2021-08-19 | 14,000 | $10.79 | $151.1K | 190,470 | SEC↗ |
| Erdtmann Rainer M | President & COO | P Buy | 2021-08-17 | 2021-08-19 | 14,000 | $10.79 | $151.1K | 190,470 | SEC↗ |
| Valle Franco | Chief Financial Officer | A Award deriv | 2021-08-03 | 2021-08-05 | 165,000 | — | $0 | 165,000 | SEC↗ |
| Ray Sumita | Director | A Award deriv | 2021-06-16 | 2021-06-21 | 17,724 | — | $0 | 17,724 | SEC↗ |
| Cormorant Asset Management, LP | 10% Owner | C Conversion deriv | 2021-04-20 | 2021-04-22 | 2,270,872 | — | $0 | 0 | SEC↗ |
| Cormorant Asset Management, LP | 10% Owner | P Buy | 2021-04-20 | 2021-04-22 | 900,000 | $17.00 | $15.30M | 3,170,872 | SEC↗ |
| Cormorant Asset Management, LP | 10% Owner | C Conversion | 2021-04-20 | 2021-04-22 | 2,270,872 | — | $0 | 2,270,872 | SEC↗ |
| Erdtmann Rainer M | President and COO | P Buy | 2021-04-15 | 2023-02-10 | 3,000 | $17.00 | $51.0K | 3,000 | SEC↗ |
| Erdtmann Rainer M | President and COO | P Buy | 2021-04-15 | 2023-02-10 | 3,000 | $17.00 | $51.0K | 3,000 | SEC↗ |
| Erdtmann Rainer M | President and COO | P Buy | 2021-04-15 | 2023-02-10 | 2,400 | $17.00 | $40.8K | 2,400 | SEC↗ |
| Butler Thomas Andrew | CEO | P Buy | 2021-04-15 | 2021-08-19 | 176,470 | $17.00 | $3.00M | 176,470 | SEC↗ |
| Erdtmann Rainer M | President & COO | P Buy | 2021-04-15 | 2021-08-19 | 176,470 | $17.00 | $3.00M | 176,470 | SEC↗ |
| Hitchcock Michael J.M. | Director | A Award deriv | 2021-04-15 | 2021-04-19 | 28,911 | — | $0 | 28,911 | SEC↗ |
| Stergiopoulos Sotirios | Director | A Award deriv | 2021-04-15 | 2021-04-19 | 28,911 | — | $0 | 28,911 | SEC↗ |
| AGUIAR ERIC | Director | A Award deriv | 2021-04-15 | 2021-04-19 | 28,911 | — | $0 | 28,911 | SEC↗ |
| Cormorant Private Healthcare F | 10% Owner | A Award deriv | 2021-04-15 | 2021-04-19 | 28,911 | — | $0 | 28,911 | SEC↗ |